Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents
نویسندگان
چکیده
منابع مشابه
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
BACKGROUND The clinical impact of late incomplete stent apposition (ISA) for drug-eluting stents is unknown. We sought to prospectively investigate the incidence and extent of ISA after the procedure and at 6-month follow-up of paclitaxel-eluting stents in comparison with bare metal stents (BMS) and survey the clinical significance of ISA over a period of 12 months. METHODS AND RESULTS TAXUS ...
متن کاملDrug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis.
D rug-eluting stents (DES) represent the gold standard device for percutaneous coronary intervention (1). Nevertheless, bare-metal stents (BMS) are still used in patients at high bleeding risk or if immediate surgery is pending, to allow shorter dual-antiplatelet therapy duration in comparison with DES. Furthermore, economic restraints and limited availability of DES in some regions justify con...
متن کاملSerial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
BACKGROUND The time course of neointimal formation after stent implantation has not been studied extensively by angioscopy in the drug-eluting stent era. METHODS AND RESULTS Serial angioscopic findings at first follow-up (3.6+/-1.1 months), second follow-up (10.5+/-1.6 months), and third follow-up (21.2+/-2.2 months) after stent implantation were compared between sirolimus-eluting stents (SES...
متن کاملThrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantation.
BACKGROUND Thrombogenicitiy of drug-eluting stents is a matter of controversial debate. The aim of this study was to evaluate the thrombogenicity of sirolimus-eluting stents (SES) compared to bare metal stents (BMS) in a standardised in vitro model. MATERIALS AND METHODS Nine SES and nine BMS were implanted in tubing loops and nine loops without stent served as controls. Initially and after 9...
متن کاملLong-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
BACKGROUND Sirolimus-eluting stents have been increasingly used for treatment of restenosis after implantation of bare metal stents (BMSs) or drug-eluting stents (DESs), but little is known regarding their long-term outcomes. METHODS We compared long-term clinical outcomes in 295 patients treated with sirolimus-eluting stents for post-BMS (n = 224) vs. post-DES (n = 71) restenosis. All follow...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2005
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.0000155607.54922.16